脑微出血与卒中相关性研究进展

doi:10.3969/j.issn.1673-5765.2020.04.007

摘要/Abstract

摘要：

脑微出血是脑小血管病的重要影像学表现之一，目前检出率随着影像学技术的进步而显著提升。研究显示脑微出血可能与缺血性卒中和脑出血风险增加相关，对未来卒中发生、发展具有一定预测价值，有助于指导卒中高危人群筛查及防治。脑微出血是否增加抗栓治疗后出血转化风险，以及相应风险是否与抗栓治疗获益相抵，目前仍有争议，是亟待解决的临床难题。临床工作中应综合评估抗栓治疗的预防获益及出血风险，以制订合理的治疗策略。

文章导读： 脑微出血与卒中发生、发展及治疗后转归密切相关，应视为危险因素指导风险-效益评估。

关键词: 脑微出血; 脑出血; 抗栓治疗

Abstract:

Cerebral microbleeds (CMBs) is one of the important imaging features of cerebral small vessel disease, and their detection rate increases significantly with the progress of imaging technology. Studies have shown that CMBs may be associated with the increased risk of ischemic stroke and cerebral hemorrhage, so CMBs maybe have certain predictive value for the occurrence and development of future stroke, which can help guide the screening and prevention of high-risk population of stroke. Whether CMBs can increase the risk of hemorrhagic transformation after antithrombotic therapy and whether this risk can offset the benefit of antithrombotic therapy are still controversial, which is an urgent clinical problem to be solved. In clinical practice, the prevention benefit and bleeding risk of antithrombotic therapy should be comprehensively evaluated so as to make reasonable and individualized treatment strategy.

Key words: Cerebral microbleeds; Intracerebral hemorrhage; Antithrombotic therapy

姚浙吕，徐运. 脑微出血与卒中相关性研究进展[J]. 中国卒中杂志, 2020, 15(04): 365-370.

YAO Zhe-Lyu, XU Yun. Progress in the Correlation between Cerebral Microbleeds and Stroke[J]. Chinese Journal of Stroke, 2020, 15(04): 365-370.

参考文献

[1] POELS M M，VERNOOIJ M W，IKRAM M A，et al.

Prevalence and risk factors of cerebral microbleeds：

an update of the Rotterdam scan study[J]. Stroke，

2010，41（10）：S103-S106.

[2] KIM B J，LEE E J，KWON S U，et al. Prevention of cardiovascular events in Asian patients with

ischaemic stroke at high risk of cerebral haemorrhage

（PICASSO）：a multicentre，randomised controlled

trial[J]. Lancet Neurol，2018，17（6）：509-518.

[3] GAO Z，ZHAI Y，ZHAO X，et al. Deep cerebral

microbleeds are associated with the severity of

lacunar infarcts and hypertension：a retrospective

analysis[J/OL]. Medicine（Baltimore），2018，97

（23）：e11031[2019-12-01]. https：//doi. org/10. 1097/

MD. 0000000000011031.

[4] JEON S B，KWON S U，CHO A H，et al. Rapid

appearance of new cerebral microbleeds after acute

ischemic stroke[J]. Neurology，2009，73（30）：1638-

1644.

[5] AKOUDAD S，PORTEGIES M L，KOUDSTAAL

P J，et al. Cerebral microbleeds are associated with

an increased risk of stroke：the Rotterdam Study[J].

Circulation，2015，132（6）：509-516.

[6] DEBETTE S，SCHILLING S，DUPERRON M G，

et al. Clinical significance of magnetic resonance

imaging markers of vascular brain injury：a

systematic review and meta-analysis[J]. JAMA

Neurol，2019，76（1）：81-94.

[7] LIM J S，HONG K S，KIM G M，et al. Cerebral

microbleeds and early recurrent stroke after transient

ischemic attack：results from the Korean transient

ischemic attack expression registry[J]. JAMA Neurol，

2015，72（3）：301-308.

[8] WILSON D，AMBLER G，LEE K J，et al. Cerebral

microbleeds and stroke risk after ischaemic stroke

or transient ischaemic attack：a pooled analysis of

individual patient data from cohort studies[J]. Lancet

Neurol，2019，18（7）：653-665.

[9] WILSON D，AMBLER G，SHAKESHAFT C，et al.

Cerebral microbleeds and intracranial haemorrhage

risk in patients anticoagulated for atrial fibrillation

after acute ischaemic stroke or transient ischaemic

attack（CROMIS-2）：a multicentre observational

cohort study[J]. Lancet Neurol，2018，17（6）：539-

547.

[10] LAU K K，WONG Y K，TEO K C，et al. Long-term

prognostic implications of cerebral microbleeds in

Chinese patients with ischemic stroke[J/OL]. J Am

Heart Assoc，2017，6（12）：e007360[2019-12-01].

https：//doi.org/10.1161/JAHA.117.007360.

[11] CHARIDIMOU A，KAKAR P，FOX Z，et al.

Cerebral microbleeds and recurrent stroke risk：

systematic review and meta-analysis of prospective

ischemic stroke and transient ischemic attack

cohorts[J]. Stroke，2013，44（4）：995-1001.

[12] WEI C，LIU J，LI J，et al. A non-linear association

between total small vessel disease score and

hemorrhagic transformation after ischemic stroke

with atrial fibrillation and/or rheumatic heart

disease[J/OL]. Front Neurol，2019，10：769[2019-12-

01]. https：//doi.org/10.3389/fneur.2019.00769.

[13] KIM B J，LEE S H. Cerebral microbleeds：their

associated factors，radiologic findings，and clinical

implications[J]. J Stroke，2013，15（3）：153-163.

[14] GREENBERG S M，ENG J A，NING M，et al.

Hemorrhage burden predicts recurrent intracerebral

hemorrhage after lobar hemorrhage[J]. Stroke，2004，

35（6）：1415-1420.

[15] CHARIDIMOU A，BOULOUIS G，XIONG L，et

al. Cortical superficial siderosis evolution[J]. Stroke，

2019，50（4）：954-962.

[16] CHARIDIMOU A，LINN J，VERNOOIJ M W，et al.

Cortical superficial siderosis：detection and clinical

significance in cerebral amyloid angiopathy and

related conditions[J]. Brain，2015，138（Pt 8）：2126-

2139.

[17] MARTÍ-FÀBREGAS J，DELGADO-MEDEROS

R，GRANELL E，et al. Microbleed burden

and hematoma expansion in acute intracerebral

hemorrhage[J]. Eur Neurol，2013，70（3-4）：175-178.

[18] BOULOUIS G，VAN ETTEN E S，CHARIDIMOU

A，et al. Association of key magnetic resonance

imaging markers of cerebral small vessel disease

with hematoma volume and expansion in patients

with lobar and deep intracerebral hemorrhage[J].

JAMA Neurol，2016，73（12）：1440-1447.

[19] SHOAMANESH A，MOROTTI A，ROMERO J M，

et al. Cerebral microbleeds and the effect of intensive

blood pressure reduction on hematoma expansion

and functional outcomes：a secondary analysis of

the ATACH-2 randomized clinical trial[J]. JAMA

Neurol，2018，75（7）：850-859.

[20] LIOUTAS V A，WU B，NORTON C，et al.

Cerebral small vessel disease burden and functional

and radiographic outcomes in intracerebral

hemorrhage[J]. J Neurol，2018，265（12）：2803-

2814.

[21] FURLAN A，HIGASHIDA R，WECHSLER L，et al. al. Predictors of new remote cerebral microbleeds

after IV thrombolysis for ischemic stroke[J/OL].

Neurology，2019，92（7）：e630-e638[2019-12-01].

https：//doi.org/10.1212/WNL.0000000000006915.

[24] CHARIDIMOU A，TURC G，OPPENHEIM C，et al.

Microbleeds，cerebral hemorrhage，and functional

outcome after stroke thrombolysis[J]. Stroke，2017，

48（8）：2084-2090.

[25] CHARIDIMOU A，SHOAMANESH A，WILSON

D，et al. Cerebral microbleeds and postthrombolysis

intracerebral hemorrhage risk updated metaanalysis[

J]. Neurology，2015，85（11）：924-927.

[26] WANG S，LV Y，ZHENG X，et al. The impact of

cerebral microbleeds on intracerebral hemorrhage

and poor functional outcome of acute ischemic

stroke patients treated with intravenous thrombolysis：

a systematic review and meta-analysis[J]. J Neurol，

2017，264（7）：1309-1319.

[27] SOO Y O，YANG S R，LAM W W，et al. Risk vs

benefit of anti-thrombotic therapy in ischaemic

stroke patients with cerebral microbleeds[J]. J Neurol，

2008，255（11）：1679-1686.

[28] CHARIDIMOU A，KAKAR P，FOX Z，et al.

Cerebral microbleeds and the risk of intracerebral

haemorrhage after thrombolysis for acute ischaemic

stroke：systematic review and meta-analysis[J]. J

Neurol Neurosurg Psychiatry，2013，84（3）：277-

280.

[29] POWERS W J，RABINSTEIN A A，ACKERSON

T，et al. Guidelines for the early management of

patients with acute ischemic stroke：2019 update

to the 2018 guidelines for the early management of

acute ischemic stroke: a guideline for healthcare

professionals from the American Heart Association/

American Stroke Association[J]. Stroke，2019，

50（12）：e344-e418[2019-12-01]. https：//doi.

org/10.1161/STR.0000000000000211.

[30] LIU S，LI C. Antiplatelet drug use and cerebral

microbleeds：a meta-analysis of published studies[J].

J Stroke Cerebrovasc Dis，2015，24（10）：2236-

2244.

[31] QIU J，YE H，WANG J，et al. Antiplatelet therapy，

cerebral microbleeds，and intracerebral hemorrhage：

a meta-analysis[J]. Stroke，2018，49（7）：1751-1754.

[32] LAU K K，LOVELOCK C E，LI L，et al.

Antiplatelet treatment after transient ischemic

attack and ischemic stroke in patients with cerebral

microbleeds in 2 large cohorts and an updated

systematic review[J]. Stroke，2018，49（6）：1434-

1442.

[33] AL-SHAHI S R，MINKS D P，MITRA D，et al.

Effects of antiplatelet therapy on stroke risk by brain

imaging features of intracerebral haemorrhage and

cerebral small vessel diseases：subgroup analyses

of the RESTART randomised，open-label trial[J].

Lancet Neurol，2019，18（7）：643-652.

[34] SELIM M，DIENER H C. Atrial fibrillation and

microbleeds[J]. Stroke，2017，48（10）：2660-2664.

[35] CHENG Y，WANG Y，SONG Q，et al. Use of

anticoagulant therapy and cerebral microbleeds：a

systematic review and meta-analysis[J/OL]. J Neurol，

2019[2019-12-01]. https：//doi.org/10.1007/s00415-

019-09572-x.

[36] MARTI-FABREGAS J，MEDRANO-MARTORELL

S，MERINO E，et al. MRI predicts intracranial

hemorrhage in patients who receive long-term oral

anticoagulation[J/OL]. Neurology，2019，92（21）：

e2432-e2443[2019-12-01]. https：//doi.org/10.1212/

WNL.0000000000007532.

[37] CHARIDIMOU A，IMAIZUMI T，MOULIN S，

et al. Brain hemorrhage recurrence，small vessel

disease type，and cerebral microbleeds：a metaanalysis[

J]. Neurology，2017，89（8）：820-829.

[38] CHARIDIMOU A，BOULOUIS G，SHAMS S，et

al. Intracerebral haemorrhage risk in microbleedpositive

ischaemic stroke patients with atrial

fibrillation：preliminary meta-analysis of cohorts

and anticoagulation decision schema[J]. J Neurol Sci，

2017，378：102-109.

[39] SAITO T，KAWAMURA Y，SATO N，et al.

Non-vitamin k antagonist oral anticoagulants do

not increase cerebral microbleeds[J]. J Stroke

Cerebrovasc Dis，2015，24（6）：1373-1377.

[40] SOO Y，ABRIGO J，LEUNG K T，et al. Correlation

of non-vitamin K antagonist oral anticoagulant

exposure and cerebral microbleeds in Chinese

patients with atrial fibrillation[J]. J Neurol Neurosurg

Psychiatry，2018，89（7）：680-686.

Intra-arterial prourokinase for acute ischemic stroke.

The PROACT II study：a randomized controlled

trial. Prolyse in acute cerebral thromboembolism[J].

JAMA，1999，282（21）：2003-2011.

[22] KIDWELL C S，SAVER J L，VILLABLANCA J

P，et al. Magnetic resonance imaging detection

of microbleeds before thrombolysis：an emerging

application[J]. Stroke，2002，33（1）：95-98.

[23] BRAEMSWIG T B，VILLRINGER K，TURC G，et